National Alliance on Mental Illness
page printed from http://www.nami.org/
(800) 950-NAMI; email@example.com
NIMH Schizophrenia Lecture Series: Cognitive Impairment in Schizophrenia
Many people who live with a diagnosis of mental illness may wonder where that diagnosis comes from. How do doctors decide what schizophrenia is or who has it? Equally, many people have questions about their medications. Why do they work? How do scientists develop them? At heart, these questions have to do with the relationship people have with their diagnoses, and how much control they can expect to have over their outcome.
All of these issues were addressed in a free online lecture given on April 5, 2010 by National Institute of Mental Health (NIMH) researchers Daniel R. Weinberger, M.D., and Jose A. Apud, M.D., Ph.D. The presentation shows the faces and thinking behind the psychiatric care that filters down to real people living with mental illness. It’s refreshing to hear that researchers have “vituperative” discussions about the validity of gene markers for schizophrenia: these people are passionate about understanding the condition and improving available treatments.
The talk traces science’s understanding of schizophrenia from Ancient Egypt to the modern day. Even if you don’t follow all the theory, the many brightly colored diagrams about molecular medicine will reinforce that this is an exploding field just as vibrant as the individuals it studies.
Listen to the lecture at the NIH Web site.